Physician profile
Gilbert K Lee
NPI 1891998258
$1,821.06
in general payments reported to CMS, 2019-2025
11 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2022: $115 · 2023: $706 · 2024: $380 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Travel and Lodging: $31.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.48 |
| Travel and Lodging | $31.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $410.33 | 2019-2025 | Descovy, Yeztugo |
| Viiv Healthcare Company | $302.93 | 2022-2023 | Apretude |
| Exact Sciences Corporation | $203.12 | 2023-2024 | Cologuard Collection Kit |
| Motiva USA, LLC | $173.65 | 2024 | |
| Medtronic, INC. | $146.66 | 2023 | Percept PC Brainsense |
| Rti Surgical, INC | $135.00 | 2025 | |
| W. L. Gore & Associates, INC. | $125.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $115.91 | 2023 | Rexulti |
| Idorsia Pharmaceuticals US INC | $115.47 | 2023 | Quviviq |
| Dynavax Technologies Corporation | $69.50 | 2025 | Heplisav-B |
| Rxsight INC | $23.49 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.